During the past decade, Pittsburgh Ear Associates conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Pittsburgh Ear Associates" are "Conductive Hearing Loss" (1 trials), "Hearing Loss" (1 trials), "Hearing Loss, Sensorineural" (1 trials), "High Frequency Sensorineural Hearing Loss" (1 trials) and "Mixed Hearing Loss" (1 trials). Many other conditions were trialed in "Pittsburgh Ear Associates" in a lesser frequency.

Most popular intervention types in "Pittsburgh Ear Associates" are "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Nucleus Hybrid L24 Implant" (1 trials), "Sophono Bone Conduction Hearing Systems" (1 trials), "Sound amplification provided via the EarLens CHD" (1 trials) and "Vibrant Soundbridge" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pittsburgh Ear Associates" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Pittsburgh Ear Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Pittsburgh Ear Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pittsburgh Ear Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".